Foresite Capital
Foresite Capital, established in 2011, is a San Francisco-based healthcare and life sciences investment firm with approximately $2 billion under management. It takes a data-driven, collaborative approach to investing, providing not just capital but also a multidisciplinary team of experts to support its portfolio companies. Foresite focuses on growth equity investments across the U.S. healthcare sector, with a particular interest in startups that leverage biology, big data, and technology to improve healthcare outcomes. Its portfolio includes companies like 10x Genomics, Relay Therapeutics, and Element Biosciences. The firm aims to address areas of great unmet clinical need and supports promising healthcare and life sciences businesses at all stages of their development.
Juvenescence
Seed Round in 2018
Juvenescence Limited is a British Virgin Islands-based holding company focused on investing in the fields of human aging and longevity. The company aims to develop a comprehensive ecosystem of assets that target aging, age-related diseases, and regenerative medicine. By leveraging advancements in scientific and medical research, Juvenescence seeks to create therapeutics that significantly extend both healthspan and lifespan. Their approach involves forming partnerships with leading scientists and research institutions, in-licensing compounds from academia and industry, and developing novel therapies based on a deep understanding of the biological mechanisms of aging. Juvenescence's initiatives also encompass therapeutic strategies aimed at promoting healthy aging, metabolic health, and brain health, with the ultimate goal of addressing the societal implications of an aging population.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.